<?xml version="1.0" encoding="UTF-8"?>
<p id="Par42">The hallmarks of COVID-19 treatment are currently antiviral drugs, drugs interfering with viral entry, and immunosuppressive drugs (mainly the ones targeting cytokines). Here, we will primarily focus on drugs that are used in rheumatology practice. Since an early strong immune response is required for the effective clearance of the virus while the following exaggerated adaptive immune response should be tuned, the timing and the duration of immunosuppressive therapies are very critical.</p>
